| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/15/2003 | CN1391608A Cloning, expression and characterisation of gene expressed in tumour cells and involved in regulation of immune response |
| 01/15/2003 | CN1391605A Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 01/15/2003 | CN1391604A Medium for protein-free and serum-free cultivation of cells |
| 01/15/2003 | CN1391581A Endogenous and non-endogenous versions of human G protein-coupled receptors |
| 01/15/2003 | CN1391579A HEV antigenic peptide and its method |
| 01/15/2003 | CN1390944A Method for increasing taxusol content in cultured substance of south enqlish yew cells by use of rare-earth element |
| 01/15/2003 | CN1098690C Microencapsulated bovine adrenal medulla chromaffincell medicine used for treating Parkinson's disease |
| 01/14/2003 | US6506962 Disease resistance |
| 01/14/2003 | US6506893 Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds |
| 01/14/2003 | US6506891 Cell surface molecule-induced macrophage activation |
| 01/14/2003 | US6506883 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic use |
| 01/14/2003 | US6506881 Specific for human milk fat globule; complementarity determining region derived from variable domains of mouse monoclonal antibody |
| 01/14/2003 | US6506875 Diagnostic epitopes |
| 01/14/2003 | US6506604 Retroviral packaging system |
| 01/14/2003 | US6506600 Secreting products from skin by adeno-associated virus (AAV) gene transfer |
| 01/14/2003 | US6506599 Method for culturing langerhans islets and islet autotransplantation islet regeneration |
| 01/14/2003 | US6506598 Gene expression of tissue plasminogen activator in butyrate salt |
| 01/14/2003 | US6506586 Nucleic acids encoding polypeptides having haloperoxidase activity |
| 01/14/2003 | US6506580 Splice variants for human 5-HT4 serotonin receptor and their applications, in particular for screening |
| 01/14/2003 | US6506576 Serum-and steroid-free culture media for cerebellar granule neurons |
| 01/14/2003 | US6506574 Drug screening, liver replenishment; culturing with cellular differentiation agent |
| 01/14/2003 | US6506559 Molecular hybridization of complementary strands |
| 01/14/2003 | US6506415 Method of inducing resistance to tumor growth |
| 01/14/2003 | US6506381 Modified red blood cell that has surface molecules that neutralize chemical agents |
| 01/14/2003 | CA2102595C Truncated forms of the hepatocyte growth factor (hgf) receptor |
| 01/09/2003 | WO2003003010A1 Pael receptor, cells and animal expressing pael receptor and method of screening remedy for parkinson’s disease |
| 01/09/2003 | WO2003002749A2 Methods for the simultaneous detection of hcv antigens and hcv antibodies |
| 01/09/2003 | WO2003002734A1 Anticomplement polypeptide from salivary glands of the tick ixodes ricinus |
| 01/09/2003 | WO2003002730A2 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
| 01/09/2003 | WO2003002722A2 T cell regulatory genes and methods of use thereof |
| 01/09/2003 | WO2003002721A2 Compositions and methods for inferring a response to a statin |
| 01/09/2003 | WO2003002711A2 A NOVEL GROUP OF α-AMYLASES AND A METHOD FOR IDENTIFICATION AND PRODUCTION OF NOVEL α-AMYLASES |
| 01/09/2003 | WO2003002710A2 Artificial synapse chip interface for electronic prosthetic retina |
| 01/09/2003 | WO2003002709A2 Novel technology for genetic mapping |
| 01/09/2003 | WO2003002610A1 Extracellular messengers |
| 01/09/2003 | WO2003002609A2 Dual-specific ligand and its use |
| 01/09/2003 | WO2003002604A2 G protein coupled receptors and dna sequences thereof |
| 01/09/2003 | WO2003002598A2 Peptides for use as translocation factors |
| 01/09/2003 | WO2003002173A1 Process and apparatus for utilization of in vivo extracted plasma with tissue engineering devices, bioreactors, artificial organs, and cell therapy applications |
| 01/09/2003 | WO2003002155A1 Vector encoding human globlin gene and use thereof in treatment of hemoglobinopathies |
| 01/09/2003 | WO2003002154A1 Artificial autologous skin secreting leptin and method for obtaining the same |
| 01/09/2003 | WO2003002137A2 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy homeostasis |
| 01/09/2003 | WO2003002044A2 Method of inhibiting the proliferation of vascular smooth muscle cells |
| 01/09/2003 | WO2003001981A2 Method of promoting engraftment of a donor transplant in a recipient host |
| 01/09/2003 | WO2003001908A1 Hspc150-like gene disruptions, compositions and methods related thereto |
| 01/09/2003 | WO2003001907A1 Nmp35 apoptosis inhibitor gene disruptions compositions and methods related thereto |
| 01/09/2003 | WO2003001892A2 Heparin-binding factors in tissue repair, regeneration and bioengineering |
| 01/09/2003 | WO2003001883A2 Gaba b1a receptor disruptions, compositions and methods relating thereto |
| 01/09/2003 | WO2003001882A2 Putative neurotransmitter receptor (pnr) disruptions, compositions and methods relating thereto |
| 01/09/2003 | WO2003001876A2 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 01/09/2003 | WO2002092825A3 Retroviral vectors for gene therapy |
| 01/09/2003 | WO2002092795A3 Intracellular bonding of costimulatory molecules |
| 01/09/2003 | WO2002087612A3 Use of stimulated peripheral blood mononuclear cells for treating cancerous diseases |
| 01/09/2003 | WO2002083707A9 Tub antisense constructs |
| 01/09/2003 | WO2002078630A8 Tub 3'-variant |
| 01/09/2003 | WO2002074796A3 Histidine phosphatase interacting protein with 240kd |
| 01/09/2003 | WO2002064756A3 Stem cell identification |
| 01/09/2003 | WO2002055658A3 Identification and characterization of an anthocyanin mutant (ant1) in tomato |
| 01/09/2003 | WO2002046373A9 Method of collecting placental stem cells |
| 01/09/2003 | WO2002044320A3 Human elongase genes and uses thereof |
| 01/09/2003 | WO2002042437A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 01/09/2003 | WO2002038774A3 Bacterial phytases and method for producing same |
| 01/09/2003 | WO2002036625A3 Prokineticin polypeptides, related compositions and methods |
| 01/09/2003 | WO2002032953A3 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 01/09/2003 | WO2002032943A3 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 01/09/2003 | WO2002024726A3 Olfactory and pheromones g-protein coupled receptors |
| 01/09/2003 | WO2002018569A3 Methods for preparing human thrombopoietin polypeptides by mammalian cell cultures |
| 01/09/2003 | WO2002014485A3 Kallikrein gene |
| 01/09/2003 | WO2002000017A3 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5 |
| 01/09/2003 | WO2001098510A3 Dna encoding a plant lipase, transgenic plants and a method for controlling senescence in plants |
| 01/09/2003 | WO2001098351A3 G-protein coupled receptors |
| 01/09/2003 | WO2001079480A9 Albumin fusion proteins |
| 01/09/2003 | WO2001057267A9 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 01/09/2003 | WO2001055336A9 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 01/09/2003 | WO2001055333A9 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
| 01/09/2003 | WO2001053504A9 Replication deficient adenovirus vectors |
| 01/09/2003 | US20030009784 Expression of trehalose biosynthetic genes in plants |
| 01/09/2003 | US20030009777 Using galanin agonist in the generation of medicament for the treatment of nerve damage |
| 01/09/2003 | US20030009020 Gene originating in human chondrocyte |
| 01/09/2003 | US20030009013 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030009012 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030008866 Bicyclic inhibitors of glycogen synthase kinase 3 |
| 01/09/2003 | US20030008838 Method of increasing endogenous leptin production |
| 01/09/2003 | US20030008837 Therapy |
| 01/09/2003 | US20030008836 Eukaryotic gene expression cassette and uses thereof |
| 01/09/2003 | US20030008815 For diagnosis and therapy of immune related disease in mammals, including humans; tumor therapy |
| 01/09/2003 | US20030008813 Intracellular protein delivery compositions and methods of use |
| 01/09/2003 | US20030008399 Controlling viral replication or gene expression in a cell; obtain cell infected with virus, transform with nucleotide sequence expressng preferential replicases, monitor viral gene expression |
| 01/09/2003 | US20030008398 Nucleotide sequences coding polypeptide for use in the treatment of autoimmune and inflammatory diseases |
| 01/09/2003 | US20030008397 Joining adhesive glycoprotein to solid support; generate solid support, incubate with glycoprotein, expose acetalaldehyde, expose to reducing agent, recover solid support |
| 01/09/2003 | US20030008395 Process for growing tissue in a biocompatible macroporous polymer scaffold and products therefrom |
| 01/09/2003 | US20030008394 Method for culturing langerhans islets and islet autotransplantation islet regeneration |
| 01/09/2003 | US20030008393 Cell culture for use as tools in treatment of cancer and metabolic diseases |
| 01/09/2003 | US20030008392 Primate embryonic stem cells |
| 01/09/2003 | US20030008391 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/09/2003 | US20030008390 Genetically engineered cell for use in the generation of viral vector for use in gene therapy |
| 01/09/2003 | US20030008389 Disposable cell culture vessel |
| 01/09/2003 | US20030008376 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/09/2003 | US20030008375 Generation of preferential adenoviral expression vector; obtain cells, infect with virus, harvest and lyse cell, recover vectors |
| 01/09/2003 | US20030008371 Cloning and characterization of a human adenylyl cyclase |